{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:08:37Z","timestamp":1771938517729,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"am","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009226","name":"National Security Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Theoretical Biology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jtbi.2019.110003","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T11:09:01Z","timestamp":1568027341000},"page":"110003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The Vicodin abuse problem: A mathematical approach"],"prefix":"10.1016","volume":"483","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6076-5636","authenticated-orcid":false,"given":"Wendy K.","family":"Caldwell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke","family":"Settles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika T.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Wirkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtbi.2019.110003_bib0003","unstructured":"Azzopardi, V., 2013. Controlling controlled substances: the balance between proper pain management and preventing drug abuse, http:\/\/rxethics.org\/Azzopardi%20Edited%%20PDF.pdf."},{"key":"10.1016\/j.jtbi.2019.110003_bib0004","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/oso\/9780195300550.003.0004","article-title":"The growth of prescription opioid abuse","volume":"18","author":"Comer","year":"2008","journal-title":"Pain Chem. Depend."},{"issue":"2","key":"10.1016\/j.jtbi.2019.110003_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the united states: concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.jtbi.2019.110003_bib0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1151\/ascp074145","article-title":"Managing addiction as a chronic condition","volume":"4","author":"Dennis","year":"2007","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.jtbi.2019.110003_bib0007","article-title":"Vicodin abuse signs, symptoms and addiction treatment","author":"drugabuse.com","year":"2013","journal-title":"Pain Phys"},{"issue":"1","key":"10.1016\/j.jtbi.2019.110003_bib0008","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2010.05.017","article-title":"Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the troup study","volume":"112","author":"Edlund","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.jtbi.2019.110003_bib0009","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1526-4637.2007.00370.x","article-title":"What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse\/addiction and\/or aberrant drug-related behaviors? A structured evidence-based review","volume":"9","author":"Fishbain","year":"2008","journal-title":"Pain Med."},{"key":"10.1016\/j.jtbi.2019.110003_bib0010","unstructured":"IMS Institute for Healthcare Informatics, 2011. The use of medicine in the United States: Review of 2010."},{"issue":"11","key":"10.1016\/j.jtbi.2019.110003_bib0014","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.jtbi.2019.110003_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.seps.2010.07.006","article-title":"Optimal control intervention strategies in low-and high-risk problem drinking populations","volume":"44","author":"Lee","year":"2010","journal-title":"Socio-Econ. Plan. Sci."},{"issue":"2","key":"10.1016\/j.jtbi.2019.110003_bib0016","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/foc.1.2.125","article-title":"Substance-related disorders","volume":"1","author":"Mack","year":"2003","journal-title":"FOCUS: J. Lifelong Learn. Psychiatry"},{"key":"10.1016\/j.jtbi.2019.110003_bib0017","series-title":"Technical Report","article-title":"Population distribution and change: 2000 to 2010","author":"Mackun","year":"2011"},{"issue":"3","key":"10.1016\/j.jtbi.2019.110003_bib0018","doi-asserted-by":"crossref","first-page":"399","DOI":"10.36076\/ppj.2007\/10\/399","article-title":"National drug control policy and prescription drug abuse: facts and fallacies","volume":"10","author":"Manchikanti","year":"2007","journal-title":"Pain Phys."},{"issue":"1","key":"10.1016\/j.jtbi.2019.110003_bib0019","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jtbi.2008.04.011","article-title":"A methodology for performing global uncertainty and sensitivity analysis in systems biology","volume":"254","author":"Marino","year":"2008","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.jtbi.2019.110003_bib0020","series-title":"Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors","author":"Marlatt","year":"2005"},{"issue":"3","key":"10.1016\/j.jtbi.2019.110003_bib0021","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.addbeh.2006.05.022","article-title":"Motives, diversion and routes of administration associated with nonmedical use of prescription opioids","volume":"32","author":"McCabe","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.jtbi.2019.110003_bib0022","unstructured":"McClanahan, K., 2015. Vicodin changes from schedule 3 to schedule 2: What this means."},{"issue":"8","key":"10.1016\/j.jtbi.2019.110003_bib0023","first-page":"12","article-title":"Advisory panel backs withdrawal of vicodin","volume":"8","author":"Mechcatie","year":"2009","journal-title":"Rheumatol. News"},{"key":"10.1016\/j.jtbi.2019.110003_bib0011","unstructured":"Michael\u2019s House, 2013a. How vicodin addiction starts - and what you can do to prevent it, www.michaelshouse.com\/featured-articles\/how-vicodin-addiction-starts."},{"key":"10.1016\/j.jtbi.2019.110003_bib0012","unstructured":"Michael\u2019s House, 2013b. Hydrocodone rehab, www.michaelshouse.com\/featured-articles\/hydrocodone-rehab."},{"key":"10.1016\/j.jtbi.2019.110003_bib0013","unstructured":"Michael\u2019s House, 2013c. Vicodin rehab statistics, http:\/\/www.michaelshouse.com\/vicodin-rehab\/real-statistics\/."},{"key":"10.1016\/j.jtbi.2019.110003_bib0024","unstructured":"O\u2019Neill, S., 2013. Kaiser program leads to huge reduction in Vicodin and Oxycontin prescriptions, Southern California Public Radio, http:\/\/www.scpr.org\/news\/2013\/04\/22\/36881\/kaiser-program-leads-to-huge-reduction-in-vicodin."},{"issue":"1","key":"10.1016\/j.jtbi.2019.110003_bib0025","first-page":"10","article-title":"CDC grand rounds: prescription drug overdoses a u.s. epidemic","volume":"61","author":"Paulozzi","year":"2012","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jtbi.2019.110003_bib0026","unstructured":"prescriptiondrugabuse.org,. Effects of vicodin abuse, http:\/\/www.prescriptiondrugabuse.org\/Effects-of-Vicodin-Abuse.htm."},{"key":"10.1016\/j.jtbi.2019.110003_bib0027","unstructured":"Rehabs.com, 2013. Choosing the best inpatient hydrocodone rehab center, http:\/\/www.rehabs.com\/about\/hydrocodone-rehab."},{"key":"10.1016\/j.jtbi.2019.110003_bib0028","series-title":"Therapist\u2019s Guide to Evidence-Based Relapse Prevention","first-page":"353","article-title":"Drinking as an epidemic? A simple mathematical model with recovery and relapse","author":"S\u00e1nchez","year":"2007"},{"issue":"3","key":"10.1016\/j.jtbi.2019.110003_bib0029","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.drugalcdep.2004.12.005","article-title":"Utilizing recovery management checkups to shorten the cycle of relapse, treatment reentry, and recovery","volume":"78","author":"Scott","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jtbi.2019.110003_bib0001","series-title":"NSDUH Series H-45, HHS Publication No. (SMA) 12-4725","article-title":"Results from the 2011 National Survey on Drug Use and Health: Mental Health Findings","year":"2012"},{"issue":"2","key":"10.1016\/j.jtbi.2019.110003_bib0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.pain.2008.04.027","article-title":"Trends in use of opioids for non-cancer pain conditions 2000\u20132005 in commercial and medicaid insurance plans: the troup study","volume":"138","author":"Sullivan","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jtbi.2019.110003_bib0031","series-title":"FDA Action on Vicodin May Mean More Pain, Not Less Addiction or Overdose","author":"Szalavitz","year":"2013"},{"issue":"1","key":"10.1016\/j.jtbi.2019.110003_bib0032","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1024630205999","article-title":"Effectiveness of school-based drug prevention programs: a meta-analysis of the research","volume":"18","author":"Tobler","year":"1997","journal-title":"J. Prim. Prev."},{"key":"10.1016\/j.jtbi.2019.110003_bib0002","unstructured":"United States Drug Enforcement Administration, 2017. Drug schedules, http:\/\/www.dea.gov\/druginfo\/ds.shtml."},{"key":"10.1016\/j.jtbi.2019.110003_bib0033","series-title":"Prescription Drugs: Abuse and Addiction","author":"Volkow","year":"2005"},{"issue":"13","key":"10.1016\/j.jtbi.2019.110003_bib0034","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/jama.2011.401","article-title":"Characteristics of opioid prescriptions in 2009","volume":"305","author":"Volkow","year":"2011","journal-title":"JAMA: J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.jtbi.2019.110003_bib0035","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.mbs.2006.10.008","article-title":"Heroin epidemics, treatment and ode modelling","volume":"208","author":"White","year":"2007","journal-title":"Math. Biosci."}],"container-title":["Journal of Theoretical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002251931930373X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002251931930373X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:25:55Z","timestamp":1758385555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002251931930373X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":35,"alternative-id":["S002251931930373X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtbi.2019.110003","relation":{},"ISSN":["0022-5193"],"issn-type":[{"value":"0022-5193","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Vicodin abuse problem: A mathematical approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Theoretical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtbi.2019.110003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110003"}}